Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
SAN DIEGO, May 6, 2026 Gallant, an emerging animal health biotechnology company focused on regenerative veterinary medicine, has announced...
Dateline Introduction – San Diego, November 10, 2025:Gallant, an animal health biotechnology leader, has achieved a pivotal regulatory milestone...
